Paper33539378
Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
Fukuyama K and 7 others. PLoS One, 2021. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters. Papers, record 33539378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33539378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblasts | Major topic |
| Gene Expression Profiling | Major topic |
| Hepatocytes | Major topic |
| Liver Neoplasms | Major topic |
| Cell Line, Tumor | |
| Gene Ontology | |
| Humans |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3479249 | Characteristics of cell lines established from human colorectal carcinoma. | Cancer Res | 1987 | https://conductscience.org/library/papers/3479249 | PubMed |
| 2 | 28144389 | Systemic treatment for hepatocellular carcinoma: Still unmet expectations. | World J Hepatol | 2017 | https://conductscience.org/library/papers/28144389 | PubMed |
| 3 | 23739536 | Clinical approval success rates for investigational cancer drugs. | Clin Pharmacol Ther | 2013 | https://conductscience.org/library/papers/23739536 | PubMed |
| 4 | 21170960 | Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. | Int J Cancer | 2011 | https://conductscience.org/library/papers/21170960 | PubMed |
| 5 | 6286115 | Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. | Cancer Res | 1982 | https://conductscience.org/library/papers/6286115 | PubMed |
| 6 | 27212245 | Role of epithelial to mesenchymal transition in hepatocellular carcinoma. | J Hepatol | 2016 | https://conductscience.org/library/papers/27212245 | PubMed |
| 7 | 22460905 | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2012 | https://conductscience.org/library/papers/22460905 | PubMed |
| 8 | 15523074 | Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. | JAMA | 2004 | https://conductscience.org/library/papers/15523074 | PubMed |
| 9 | 30404026 | Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30404026 | PubMed |
| 10 | 15688078 | What's wrong with our cancer models? | Nat Rev Drug Discov | 2005 | https://conductscience.org/library/papers/15688078 | PubMed |
| 11 | 24053356 | An expression atlas of human primary cells: inference of gene function from coexpression networks. | BMC Genomics | 2013 | https://conductscience.org/library/papers/24053356 | PubMed |
| 12 | 21646355 | Cell type-specific target selection by combinatorial binding of Smad2/3 proteins and hepatocyte nuclear factor 4alpha in HepG2 cells. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21646355 | PubMed |
| 13 | 25921660 | Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. | Clin Liver Dis | 2015 | https://conductscience.org/library/papers/25921660 | PubMed |
| 14 | 1701409 | Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines. | Hepatogastroenterology | 1990 | https://conductscience.org/library/papers/1701409 | PubMed |
| 15 | 31063779 | Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response. | Gastroenterology | 2019 | https://conductscience.org/library/papers/31063779 | PubMed |
| 16 | 233137 | Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. | Nature | 1979 | https://conductscience.org/library/papers/233137 | PubMed |
| 17 | 23239537 | Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. | Hepatology | 2013 | https://conductscience.org/library/papers/23239537 | PubMed |
| 18 | 21397858 | Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21397858 | PubMed |
| 19 | 63998 | Establishment of a continuously growing cell line from primary carcinoma of the liver. | S Afr Med J | 1976 | https://conductscience.org/library/papers/63998 | PubMed |
| 20 | 17178882 | Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. | Cancer Res | 2006 | https://conductscience.org/library/papers/17178882 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40996243 | HCC-derived SNU cell lines as model systems to study HBV life cycle. | J Virol | 2025 | https://conductscience.org/library/papers/40996243 | PubMed |
| 40715090 | Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40715090 | PubMed |
| 40507937 | Azvudine Suppresses Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Targeting the Notch-HEY Signalling Pathway. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40507937 | PubMed |
| 39835937 | Geometrically constrained cytoskeletal reorganisation modulates DNA nanostructures uptake. | J Mater Chem B | 2025 | https://conductscience.org/library/papers/39835937 | PubMed |
| 39372137 | Peptide-coated DNA nanostructures as a platform for control of lysosomal function in cells. | Chem Eng J | 2024 | https://conductscience.org/library/papers/39372137 | PubMed |
| 39062197 | Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges. | Biomedicines | 2024 | https://conductscience.org/library/papers/39062197 | PubMed |
| 37560414 | Iron oxide nanoparticles trigger endoplasmic reticulum damage in steatotic hepatic cells. | Nanoscale Adv | 2023 | https://conductscience.org/library/papers/37560414 | PubMed |
| 36278150 | Analyzing the metabolic fate of oral administration drugs: A review and state-of-the-art roadmap. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36278150 | PubMed |
| 35949600 | VEGF-mediated tumour growth and EMT in 2D and 3D cell culture models of hepatocellular carcinoma. | Oncol Lett | 2022 | https://conductscience.org/library/papers/35949600 | PubMed |
| 34830068 | Expression and Functionality of Connexin-Based Channels in Human Liver Cancer Cell Lines. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34830068 | PubMed |
| 34359553 | Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359553 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SPHK2 | 56848 | PubTator's text mining | https://conductscience.org/library/genes/56848 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33539378
GET https://conductscience.org/api/papers/v1/33539378/references?page=2